Adenosquamous carcinoma of the lung (ASC), a relatively rare subtype of non-small-cell
lung cancer, is defined as a malignancy containing components of lung adenocarcinoma …

Programmed death-ligand (PD-L) 1 and 2 are ligands of programmed cell death 1 (PD-1)
receptor. They are members of the B7/CD28 ligand-receptor family and the most …

Background Adenosquamous carcinoma (ASC) of the lung is a heterogeneous disease that
is composed of both adenocarcinoma components (ACC) and squamous cell carcinoma …

Lung adenosquamous carcinoma is a particular subtype of non-small cell lung carcinoma
that is defined by the coexistence of adenocarcinoma and squamous cell carcinoma …

The poor prognosis and fewer treatment option is a current clinical challenge for patients
with lung adenosquamous carcinoma (ASC). The previous studies reported that tumor …

Objective: Lung cancer poses a tremendous threat to the modern world. According to
Taiwan's Ministry of Health and Welfare, lung cancer took first place in total cancer deaths in …

Laryngeal cancer (LC) remains a challenging disease to treat. The majority of LCs
diagnosed worldwide are squamous cell carcinomas (SCC), and current treatment …

Lung cancer causes the most cancer-related deaths worldwide. In recent years, molecular
and immunohistochemical techniques have rapidly developed, further inaugurating an era …

Context.—Lung tumors are histologically heterogeneous, but classification of lung
carcinoma has prognostic impact and increasingly, specific molecular correlates. Objective …

Background Adenosquamous carcinoma (ADSC) of the lung, a rare but aggressive subtype
of non-small cell lung cancer (NSCLC), is defined as a carcinoma containing components of …